COVID-19 Immunity Provided Cross-Neutralization
Researchers found that antibodies from recovered patients successfully neutralize several related bat sarbecoviruses.
Updated on Oct. 1, 2026 in Diseases — General
Live Poll
Do you trust that your previous COVID-19 infection protects you against potential future coronavirus outbreaks?
A new study published in PLOS Biology reveals that immunity against SARS-CoV-2 offers cross-neutralization capabilities against various related bat coronaviruses. Scientists investigated how these viruses interact with ACE2 receptors to better understand potential cross-species transmission risks.
Why it matters
Understanding how sarbecoviruses interact with host receptors is essential for assessing the threat of future spillover events. This research provides a foundation for designing next-generation vaccines and therapies capable of targeting diverse viral threats.
Researchers analyzed interactions between 15 representative bat sarbecovirus spike proteins and ACE2 receptors derived from 34 different species. While SARS-CoV-2 and BANAL viruses showed generalist phenotypes, the U.K.-based RhGB07 virus displayed a specialized receptor usage.
The players
The Pirbright Institute
This is a world-leading research center in the United Kingdom dedicated to studying viral diseases of livestock and viruses that spread from animals to humans.
King's College London
This is a public research university located in London that frequently collaborates on global health and infectious disease projects.
The details
Scientists at The Pirbright Institute and King's College London tested blood samples from individuals who recovered from COVID-19 to determine if their antibodies could neutralize bat-derived sarbecoviruses. The team found that while immunity effectively targets closely related viruses, neutralization potency decreases against more distant sarbecovirus variants.
Timeline
October 1, 2026: The research study was published in the journal PLOS Biology.
The Big Picture
This research follows a pattern of ongoing investigation into the sarbecovirus subgenus, aiming to map the evolutionary landscape of coronaviruses. The findings update our understanding of how shared receptor usage drives the potential for cross-species viral spillover.
This discovery validates the breadth of protection generated by current COVID-19 immunity, though it highlights limits against distant viral relatives. Ongoing research into these interactions will ultimately guide the development of broader-spectrum medical countermeasures for future pandemics.
The takeaway
While existing immunity offers some protection against diverse sarbecoviruses, scientists continue to identify significant variations in how these viruses interact with human receptors. Staying informed on these evolutionary patterns helps researchers design more resilient vaccine candidates for the future.
Further reading
For more background on infectious disease research, visit the Diseases — General section.
Live Poll
Do you trust that your previous COVID-19 infection protects you against potential future coronavirus outbreaks?
